Immune checkpoint inhibitor-associated celiac disease

Time to dissect the autoimmune etiology of cancer antibody immunotherapy

(2020) Michael Dougan et al.   JOURNAL OF CLINICAL INVESTIGATION

Celiac disease: a comprehensive current review

(2019) Giacomo Caio et al.   BMC Medicine

Advances in cancer immunotherapy 2019 – latest trends

(2019) Stephan Kruger et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Adverse Events Following Cancer Immunotherapy: Obstacles and Opportunities

(2019) Kristen E. Pauken et al.   TRENDS IN IMMUNOLOGY

A case of checkpoint inhibitor-induced celiac disease

(2019) Dana Alsaadi et al.   Journal for ImmunoTherapy of Cancer

Diagnosis and Management of Rare Immune‐Related Adverse Events

(2019) Sara R. Schoenfeld et al.   ONCOLOGIST

Budesonide treatment for microscopic colitis from immune checkpoint inhibitors

(2019) Michael S. Hughes et al.   Journal for ImmunoTherapy of Cancer

Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease

(2019) Hamzah Abu-Sbeih et al.   JOURNAL OF CLINICAL ONCOLOGY

Gamma-Delta T Lymphocytes in the Diagnostic Approach of Coeliac Disease

(2018) Petula Nijeboer et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

(2018) Michael A. Postow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cancer immunotherapy using checkpoint blockade

(2018) Antoni Ribas et al.   SCIENCE

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary

(2018) Julie R. Brahmer et al.   Journal of Oncology Practice

Enterocolitis due to immune checkpoint inhibitors: a systematic review

(2018) Emilie Soularue et al.   GUT

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

(2018) Spencer C. Wei et al.   Cancer Discovery

Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case–Control Study

(2018) Yael Eshet et al.   Cancer Immunology Research

Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies

(2018) Jason A. Tye-Din et al.   Frontiers in Pediatrics

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study

(2018) Hamzah Abu-Sbeih et al.   Journal for ImmunoTherapy of Cancer

Celiac Disease and Nonceliac Gluten Sensitivity

(2017) Maureen M. Leonard et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease

(2016) L. Marthey et al.   Journal of Crohns & Colitis

Association Between Ipilimumab and Celiac Disease

(2013) Nicole M. Gentile et al.   MAYO CLINIC PROCEEDINGS

Persistent Changes in Circulating and Intestinal γδ T Cell Subsets, Invariant Natural Killer T Cells and Mucosal-Associated Invariant T Cells in Children and Adults with Coeliac Disease

(2013) Margaret R. Dunne et al.   PLoS One

The Oslo definitions for coeliac disease and related terms

(2012) Jonas F Ludvigsson et al.   GUT

Celiac Disease

(2012) Alessio Fasano et al.   NEW ENGLAND JOURNAL OF MEDICINE

PD-1 signalling in CD4+T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide-induced tolerance

(2010) Joanne E. Konkel et al.   IMMUNOLOGY

Intestinal Tolerance Is Converted to Autoimmune Enteritis upon PD-1 Ligand Blockade

(2009) E. D. Reynoso et al.   JOURNAL OF IMMUNOLOGY

Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways

(2008) Brian T. Fife et al.   IMMUNOLOGICAL REVIEWS